Literature DB >> 124817

The mutagenicity of azathioprine in mice, Drosophila melanogaster and Neurospora crassa.

J M Clark.   

Abstract

The chemotherapeutic coumpound azathioprine was tested for possible mutagenicity in Swiss Albino mice, Drosophila melanogaster and Neurospora crassa. Utilizing the dominant-lethal assay it was found that acute oral doses of azathioprine (2 times 25 mg/kg body weight), induced dominant-lethal mutations in mouse spermatocytes. Chronic oral doses of azathioprine (2 times 25 mg/kg body weight/week for 10 weeks) resulted in a greater rate of dominant-lethality. This increase was not permanent, and by week 4 of gamete sampling there was no significant increase in dominant-lethal mutations. Histological sections showed that chronic treatment of male mice with azathioprine caused pyknosis of spermatocyte nuclei and depletion of the spermatid population. Both acute and chronic doses of azathioprine caused a temporary reduction in sperm viability. Oral treatment of male Canton-S, D. melanogaster with azathioprine caused an increase in dominant-lethality in broods assumed to correspond to spermatid and spermaotcyte stages. Azathioprine also increased the rate of non-disjunction of the X and Y chromosomes, loss of the long arm of the Y chromosome, and loss of the X or Y chromosome in treated male R(I)2, vf/BsYy+D. melanogaster. Since sex-ratio deviation did not occur in progeny from treated rod-X (yv/B2Yy+) male D. melanogaster, it was concluded that the observed sex-ration deviation in the treated ring-X stock was the result of induced ring-X lethality. Azathioprine induced recessive-lethal mutations in the ad-3 region of a N. crassa heterokaryon. In the host-mediated assay using this same heterokaryon and male Swiss Albino mice as host, the mutagenic activity of azathioprine did not appear to be potentiated or detoxified by the host. The results show that azathioprine has a deleterious effect on reproduction in mice and probably induces mutational events in mice, D. melanogaster and N. crassa.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 124817     DOI: 10.1016/0027-5107(75)90318-8

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

Review 1.  The new FDA labeling rule: impact on prescribing rheumatological medications during pregnancy.

Authors:  Bonnie L Bermas; Melissa Tassinari; Megan Clowse; Eliza Chakravarty
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

2.  Modulation of genotoxicity of azathioprine by intracellular glutathione in hepatocytes.

Authors:  K Nagafuchi; K Miyazaki
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  Chromosome aberrations in 450 sperm complements from eight controls and lack of increase after chemotherapy in two patients.

Authors:  J Jenderny; M L Jacobi; A Rüger; G Röhrborn
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

Review 4.  Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations.

Authors:  Yang Mao-Draayer; Sandra Thiel; Elizabeth A Mills; Tanuja Chitnis; Michelle Fabian; Ilana Katz Sand; M Isabel Leite; Sven Jarius; Kerstin Hellwig
Journal:  Nat Rev Neurol       Date:  2020-02-20       Impact factor: 42.937

5.  Sister chromatid exchange in lymphocytes from renal transplant recipients with and without cancer.

Authors:  G E Kelly; A G Sheil
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.